LOC653566 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.575600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.114800E-01
Normal-vs-Stage2
4.693200E-01
Normal-vs-Stage3
7.587600E-01
Normal-vs-Stage4
4.769000E-01
Stage1-vs-Stage2
8.975400E-01
Stage1-vs-Stage3
3.401600E-01
Stage1-vs-Stage4
9.191400E-01
Stage2-vs-Stage3
2.233600E-01
Stage2-vs-Stage4
9.968200E-01
Stage3-vs-Stage4
3.551000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.685800E-01
Normal-vs-AfricanAmerican
1.314160E-01
Normal-vs-Asian
9.761000E-01
Caucasian-vs-AfricanAmerican
1.049760E-01
Caucasian-vs-Asian
1.967810E-01
AfricanAmerican-vs-Asian
4.672400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.951800E-01
Normal-vs-Female
4.082400E-01
Male-vs-Female
8.927000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.127800E-01
Normal-vs-Age(41-60Yrs)
1.375360E-01
Normal-vs-Age(61-80Yrs)
6.377200E-01
Normal-vs-Age(81-100Yrs)
4.777200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.526500E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.523800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.751190E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.578000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.048000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.154800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.346600E-01
Normal-vs-Daily Drinker
5.840800E-01
Normal-vs-Weekly Drinker
9.762600E-01
Normal-vs-Occasional Drinker
2.086400E-01
Normal-vs-Social Drinker
3.752800E-01
Non Drinker-vs-Daily Drinker
4.278600E-01
Non Drinker-vs-Weekly Drinker
5.080600E-01
Non Drinker-vs-Occasional Drinker
1.359810E-02
Non Drinker-vs-Social Drinker
2.568400E-01
Daily Drinker-vs-Weekly Drinker
2.735800E-01
Daily Drinker-vs-Occasional Drinker
2.054200E-01
Daily Drinker-vs-Social Drinker
8.822400E-01
Weekly Drinker-vs-Occasional Drinker
1.998490E-02
Weekly Drinker-vs-Social Drinker
1.438010E-01
Occasional Drinker-vs-Social Drinker
2.305200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.325000E-01
Normal-vs-Grade 2
1.410220E-01
Normal-vs-Grade 3
6.077600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.973600E-01
Grade 1-vs-Grade 3
7.071800E-01
Grade 1-vs-Grade 4
2.325000E-01
Grade 2-vs-Grade 3
8.572200E-01
Grade 2-vs-Grade 4
1.410220E-01
Grade 3-vs-Grade 4
6.077600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.958600E-01
Normal-vs-NonDiabetic
4.195200E-01
Diabetic-vs-NonDiabetic
7.400100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.967800E-01
Normal-vs-NoPancreatitis
5.092800E-01
Pancreatitis-vs-NoPancreatitis
9.717400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.406400E-01
Normal-vs-N1
4.413600E-01
N0-vs-N1
6.582000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.066600E-01
Normal-vs-TP53-NonMutant
4.934200E-01
TP53-Mutant-vs-TP53-NonMutant
3.186000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
